CHICAGO, Nov. 15, 2022 /PRNewswire/ Liquid Biopsy Market is projected to reach USD 10.0 billion by 2027 from USD 4.3 billion in 2022, at a CAGR of 18.3% according to a new report by MarketsandMarkets.
/PRNewswire/ The breast cancer liquid biopsy testing devices market share growth by the CTCs and circulating nucleic acids segment will be significant.
/PRNewswire/ The breast cancer liquid biopsy testing devices market share growth by the CTCs and circulating nucleic acids segment will be significant.
/PRNewswire/ The Blood Market share is expected to increase by USD 2195.69 million from 2022 to 2027, with an accelerated CAGR of 5.31% - according to a.